Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Staring down the Alzheimer’s diagnosis
By
Kimberly Marselas
Apr 25, 2023
Alzheimer’s disease may be among the most-feared diagnoses for people of a certain age, one that for many has been instantaneously life-altering. But today’s patients will force us to see it through...
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Pay good providers more to care for dementia patients, researchers urge
By
Kimberly Marselas
Feb 09, 2023
Policymakers should consider incentivizing nursing homes to take patients with Alzheimer’s disease and related dementias, argue the authors of a new study that finds such patients currently are more...